Peripheral Blood Mononuclear Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product (Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC, and Peripheral Blood Mononuclear Cell Isolation & Viability Kits), By Application (Immunology, Hematology, Infectious Disease, Hematology, and Others), By Techniques (Density Gradient Centrifugation, Leukapheresis, and Others), By Source (Human, Animals), By Region, Competition, Forecast and Opportunities
Global peripheral blood mononuclear cells market was valued at USD 235.68 million in 2022 and is anticipated to grow at a CAGR of 10.39% during the period 2023-2028 owing to the rising rate in the number of cell therapies, high demand of research, and development for toxicology testing and reaction mechanism of the compound responsible for new and stable development of products. For instance, in June 2023, a study published in the National Library of Medicine assessed the immune response of peripheral blood mononuclear cells (PBMC) that were infected in vitro with the Colombian strain (Col) of Trypanosoma cruzi and treated with Benzonidazole.
Peripheral blood mononuclear cells (PBMCs) are a type of blood cell that plays a crucial role in the immune system. PBMCs are a heterogeneous population of cells that are isolated from the peripheral blood, which is the blood circulating throughout the body. They are composed of lymphocytes, monocytes, and other immune cells. Lymphocytes are a type of white blood cell that includes T cells, B cells, and natural killer (NK) cells. T cells are responsible for cell-mediated immune responses, B cells produce antibodies for humoral immune responses, and NK cells are involved in the innate immune system and killing infected or cancerous cells. Monocytes are another type of white blood cell that circulates in the bloodstream and can differentiate into macrophages or dendritic cells when they migrate into tissues. Macrophages are responsible for engulfing and destroying foreign substances, dead cells, and cellular debris, while dendritic cells play a critical role in initiating and regulating immune responses by presenting antigens to T cells. The isolation and characterization of PBMCs have revolutionized the understanding of the immune system and have contributed to advancements in various fields, including cancer research, infectious diseases, autoimmune disorders, and transplantation medicine.
PBMCs are widely used in various research applications, including immunology, cell therapy, vaccine development, and drug discovery. They provide valuable insights into immune responses, allow researchers to study various immune cell populations, and serve as a source of cells for cell-based therapies. PBMCs can be isolated from peripheral blood using techniques such as density gradient centrifugation or specialized cell separation methods.
Additionally, the rise in number of cell therapies, expansion in research & development schemes, increasing focus of key players on R&D in peripheral blood mononuclear cells, increasing focus on regenerative medicine, as well as an increase in demand for cell operations among the population, increasing investigation of various aspects of immunology, infectious diseases, autoimmune disorders, transplantation, and vaccine development are projected to provide market players with lucrative prospects in the future.
Growing Advancement for Toxicology Research
The growing awareness of customers for peripheral blood mononuclear cells, as well as a growing preference for antibody development, are two important growth drivers for the industry. PBMC is crucial to carry out biology and pathology-related studies as well as in clinical research related to fatal diseases, immunology, vaccine development, etc. For instance, according to clinicaltirals.gov.in, 972 studies have been carried out for peripheral blood mononuclear cells. PBMCs provide information on the effects of prospective novel medication molecules on people, particularly on their immune systems. Drug toxicity that affects PBMCs can result in several serious, sometimes fatal toxic side effects, including immune system suppression and poisoning. Toxicology research aims to evaluate the potentially harmful effects of chemical substances, drugs, and environmental factors on living organisms. PBMCs are used in immunotoxicity studies to assess the impact of these substances on the immune system. By exposing PBMCs to different compounds and analyzing immune responses, researchers can determine the immunotoxic effects, including alterations in immune cell populations, cytokine production, and immune function. The demand for PBMCs in immunotoxicity research is thus increasing, contributing to the growth of the global peripheral blood mononuclear cells market.
Increasing Importance of Peripheral Blood Mononuclear Cells for Cell Therapy
Patients now have a better alternative to cell-based therapies with respect to traditional regenerative medicines, but their side effects have hindered their use among customers. In this product category, developed regions such as North America and Europe have a strong presence in cell therapies for human well-being. The population is gaining awareness regarding the use of peripheral blood mononuclear cells in cell and gene therapy. Hence, the extraction and usage of peripheral blood mononuclear cells prove to be the key driving force for market expansion. However, fatal diseases such as acute myocardial infarction, chronic heart failure, spinal cord injury, stroke, and wound healing have all been successfully treated in pre-clinical studies using the secretome of apoptotic peripheral blood mononuclear cells, which drives the market growth globally. For instance, according to the Centers for Disease Control and Prevention, around 37,300 new cases of HPV+ tumors occur each year in the U.S., accounting for 3% of all malignancies in women and 2% of all cancers in men. With the increasing prevalence of HPV in the country, companies are continuously focusing on the development of therapy and drugs to enter the US market. PBMCs serve as a valuable source of immune cells for cell therapy. They contain various types of immune cells, including T cells, B cells, and natural killer (NK) cells, which play crucial roles in immune responses and disease targeting. PBMCs provide a diverse population of immune cells that can be isolated, manipulated, and utilized in different cell therapy approaches.
Also, Adoptive Cell Transfer (ACT) is a type of cell therapy that involves the transfer of immune cells, typically T cells, into patients to target and eliminate diseases, such as cancers. PBMCs are often used as a starting material to isolate and expand specific subsets of T cells, such as tumor-infiltrating lymphocytes (TILs), tumor-associated antigen-specific T cells, or genetically engineered T cells. PBMCs provide a convenient source of T cells for ACT therapies.
Growing Investment in Research & Development for Human Well-Being
Rapid advancements in research and development (R&D) practices and activities are propelling the growth of the market as novel cell/gene therapies/medications and new products are developed for the treatment of fatal diseases. PBMCs are a reasonable way to acquire physiologically relevant (immune) proteins from routinely collected blood samples, and they do so without the native human plasma's well-known analytical challenges brought on by the presence of highly abundant proteins for driving the growth of the market. Furthermore, the government of different countries, for their growth in the healthcare sector, are providing funds for the ongoing research of peripheral blood mononuclear cells.
Additionally, the growing awareness of the potential of PBMCs in disease research has led to increased R&D activities and contributed to market growth. PBMCs play a crucial role in drug discovery and development. They are utilized in early-stage research to assess the efficacy and safety of potential drug candidates. PBMCs provide a human-relevant model for studying immune responses and evaluating the effects of new compounds on immune cells. The growing awareness of the value of PBMCs in drug discovery has resulted in increased demand and utilization of these cells, driving the growth of the PBMCs market. The awareness of the therapeutic potential of cell-based therapies has been growing rapidly. PBMCs are essential in the development and manufacturing of cell-based therapies, such as adoptive cell transfer, CAR-T cell therapy, and immunotherapies. The therapeutic benefits of these advanced therapies, coupled with the increasing awareness of PBMCs' role in their development, have led to significant R&D efforts and the growth of global peripheral blood mononuclear cells market. There has been a notable increase in collaboration between academic institutions, research organizations, and the biopharmaceutical industry. This collaboration has fostered knowledge exchange, joint research projects, and funding initiatives focused on the application of PBMCs in various areas of research. The growing awareness of the potential of PBMCs and the collaborative efforts in R&D have positively impacted the growth of the global peripheral blood mononuclear cells market.
Market Segmentation
The global peripheral blood mononuclear cells market is segmented based on product, application, technique, source, region, and competitive landscape. Based on the product, the market can be split into cryopreserved or frozen PBMC, cultured or fresh PBMC, and peripheral blood mononuclear cell isolation & viability kits. Based on application, the market can be divided into immunology, hematology, infectious disease, and others. Based on techniques, the market is divided into density gradient centrifugation, leukapheresis, and others. In terms of sources, the market can be categorized into humans and animals.
Company Profiles
Charles River Laboratories International, Inc., Lonza Group AG, Corning Inc, Bio-Rad Laboratories Inc, ABCAM, Biolegend Inc, ZEN-Bio Inc, DAPCEL, Inc., Creative Bioarray, iXCells Biotechnologies USA, LLC, Miltenyi Biotec B.V. & CO. KG, STEMCELL Technologies Inc., Precision Medicine Group, LLC, StemExpress, LLC, RayBiotech Life, Inc., REPROCELL Inc., Cytologics LLC, BioIVT LLC, Biopredic International, and Cell Applications, Inc. etc. are among the major players in the global peripheral blood mononuclear cells market.
Report Scope:
In this report, Global Peripheral Blood Mononuclear Cells Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in global peripheral blood mononuclear cells market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
Peripheral blood mononuclear cells (PBMCs) are a type of blood cell that plays a crucial role in the immune system. PBMCs are a heterogeneous population of cells that are isolated from the peripheral blood, which is the blood circulating throughout the body. They are composed of lymphocytes, monocytes, and other immune cells. Lymphocytes are a type of white blood cell that includes T cells, B cells, and natural killer (NK) cells. T cells are responsible for cell-mediated immune responses, B cells produce antibodies for humoral immune responses, and NK cells are involved in the innate immune system and killing infected or cancerous cells. Monocytes are another type of white blood cell that circulates in the bloodstream and can differentiate into macrophages or dendritic cells when they migrate into tissues. Macrophages are responsible for engulfing and destroying foreign substances, dead cells, and cellular debris, while dendritic cells play a critical role in initiating and regulating immune responses by presenting antigens to T cells. The isolation and characterization of PBMCs have revolutionized the understanding of the immune system and have contributed to advancements in various fields, including cancer research, infectious diseases, autoimmune disorders, and transplantation medicine.
PBMCs are widely used in various research applications, including immunology, cell therapy, vaccine development, and drug discovery. They provide valuable insights into immune responses, allow researchers to study various immune cell populations, and serve as a source of cells for cell-based therapies. PBMCs can be isolated from peripheral blood using techniques such as density gradient centrifugation or specialized cell separation methods.
Additionally, the rise in number of cell therapies, expansion in research & development schemes, increasing focus of key players on R&D in peripheral blood mononuclear cells, increasing focus on regenerative medicine, as well as an increase in demand for cell operations among the population, increasing investigation of various aspects of immunology, infectious diseases, autoimmune disorders, transplantation, and vaccine development are projected to provide market players with lucrative prospects in the future.
Growing Advancement for Toxicology Research
The growing awareness of customers for peripheral blood mononuclear cells, as well as a growing preference for antibody development, are two important growth drivers for the industry. PBMC is crucial to carry out biology and pathology-related studies as well as in clinical research related to fatal diseases, immunology, vaccine development, etc. For instance, according to clinicaltirals.gov.in, 972 studies have been carried out for peripheral blood mononuclear cells. PBMCs provide information on the effects of prospective novel medication molecules on people, particularly on their immune systems. Drug toxicity that affects PBMCs can result in several serious, sometimes fatal toxic side effects, including immune system suppression and poisoning. Toxicology research aims to evaluate the potentially harmful effects of chemical substances, drugs, and environmental factors on living organisms. PBMCs are used in immunotoxicity studies to assess the impact of these substances on the immune system. By exposing PBMCs to different compounds and analyzing immune responses, researchers can determine the immunotoxic effects, including alterations in immune cell populations, cytokine production, and immune function. The demand for PBMCs in immunotoxicity research is thus increasing, contributing to the growth of the global peripheral blood mononuclear cells market.
Increasing Importance of Peripheral Blood Mononuclear Cells for Cell Therapy
Patients now have a better alternative to cell-based therapies with respect to traditional regenerative medicines, but their side effects have hindered their use among customers. In this product category, developed regions such as North America and Europe have a strong presence in cell therapies for human well-being. The population is gaining awareness regarding the use of peripheral blood mononuclear cells in cell and gene therapy. Hence, the extraction and usage of peripheral blood mononuclear cells prove to be the key driving force for market expansion. However, fatal diseases such as acute myocardial infarction, chronic heart failure, spinal cord injury, stroke, and wound healing have all been successfully treated in pre-clinical studies using the secretome of apoptotic peripheral blood mononuclear cells, which drives the market growth globally. For instance, according to the Centers for Disease Control and Prevention, around 37,300 new cases of HPV+ tumors occur each year in the U.S., accounting for 3% of all malignancies in women and 2% of all cancers in men. With the increasing prevalence of HPV in the country, companies are continuously focusing on the development of therapy and drugs to enter the US market. PBMCs serve as a valuable source of immune cells for cell therapy. They contain various types of immune cells, including T cells, B cells, and natural killer (NK) cells, which play crucial roles in immune responses and disease targeting. PBMCs provide a diverse population of immune cells that can be isolated, manipulated, and utilized in different cell therapy approaches.
Also, Adoptive Cell Transfer (ACT) is a type of cell therapy that involves the transfer of immune cells, typically T cells, into patients to target and eliminate diseases, such as cancers. PBMCs are often used as a starting material to isolate and expand specific subsets of T cells, such as tumor-infiltrating lymphocytes (TILs), tumor-associated antigen-specific T cells, or genetically engineered T cells. PBMCs provide a convenient source of T cells for ACT therapies.
Growing Investment in Research & Development for Human Well-Being
Rapid advancements in research and development (R&D) practices and activities are propelling the growth of the market as novel cell/gene therapies/medications and new products are developed for the treatment of fatal diseases. PBMCs are a reasonable way to acquire physiologically relevant (immune) proteins from routinely collected blood samples, and they do so without the native human plasma's well-known analytical challenges brought on by the presence of highly abundant proteins for driving the growth of the market. Furthermore, the government of different countries, for their growth in the healthcare sector, are providing funds for the ongoing research of peripheral blood mononuclear cells.
Additionally, the growing awareness of the potential of PBMCs in disease research has led to increased R&D activities and contributed to market growth. PBMCs play a crucial role in drug discovery and development. They are utilized in early-stage research to assess the efficacy and safety of potential drug candidates. PBMCs provide a human-relevant model for studying immune responses and evaluating the effects of new compounds on immune cells. The growing awareness of the value of PBMCs in drug discovery has resulted in increased demand and utilization of these cells, driving the growth of the PBMCs market. The awareness of the therapeutic potential of cell-based therapies has been growing rapidly. PBMCs are essential in the development and manufacturing of cell-based therapies, such as adoptive cell transfer, CAR-T cell therapy, and immunotherapies. The therapeutic benefits of these advanced therapies, coupled with the increasing awareness of PBMCs' role in their development, have led to significant R&D efforts and the growth of global peripheral blood mononuclear cells market. There has been a notable increase in collaboration between academic institutions, research organizations, and the biopharmaceutical industry. This collaboration has fostered knowledge exchange, joint research projects, and funding initiatives focused on the application of PBMCs in various areas of research. The growing awareness of the potential of PBMCs and the collaborative efforts in R&D have positively impacted the growth of the global peripheral blood mononuclear cells market.
Market Segmentation
The global peripheral blood mononuclear cells market is segmented based on product, application, technique, source, region, and competitive landscape. Based on the product, the market can be split into cryopreserved or frozen PBMC, cultured or fresh PBMC, and peripheral blood mononuclear cell isolation & viability kits. Based on application, the market can be divided into immunology, hematology, infectious disease, and others. Based on techniques, the market is divided into density gradient centrifugation, leukapheresis, and others. In terms of sources, the market can be categorized into humans and animals.
Company Profiles
Charles River Laboratories International, Inc., Lonza Group AG, Corning Inc, Bio-Rad Laboratories Inc, ABCAM, Biolegend Inc, ZEN-Bio Inc, DAPCEL, Inc., Creative Bioarray, iXCells Biotechnologies USA, LLC, Miltenyi Biotec B.V. & CO. KG, STEMCELL Technologies Inc., Precision Medicine Group, LLC, StemExpress, LLC, RayBiotech Life, Inc., REPROCELL Inc., Cytologics LLC, BioIVT LLC, Biopredic International, and Cell Applications, Inc. etc. are among the major players in the global peripheral blood mononuclear cells market.
Report Scope:
In this report, Global Peripheral Blood Mononuclear Cells Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
- Peripheral Blood Mononuclear Cells Market, By Product:
- Cryopreserved or Frozen PBMC
- Cultured or Fresh PBMC
- Others
- Peripheral Blood Mononuclear Cells Market, By Application:
- Immunology
- Hematology
- Infectious Disease
- Others
- Peripheral Blood Mononuclear Cells Market, By Techniques:
- Density Gradient Centrifugation
- Leukapheresis
- Others
- Peripheral Blood Mononuclear Cells Market, By Source:
- Human
- Animal
- Peripheral Blood Mononuclear Cells Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Singapore
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
Company Profiles: Detailed analysis of the major companies present in global peripheral blood mononuclear cells market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. IMPACT OF COVID-19 ON GLOBAL PERIPHERAL BLOOD MONONUCLEAR CELLS MARKET
5. VOICE OF CUSTOMER
5.1. By Type of Product
5.2. By Type of Technique
5.3. Type of Application for Which PBMCs Are Used
5.4. Factors Driving Market Growth
6. GLOBAL PERIPHERAL BLOOD MONONUCLEAR CELLS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC and Peripheral Blood Mononuclear Cell Isolation & Viability Kits)
6.2.2. By Application (Immunology, Infectious Disease, Hematology and Others)
6.2.3. By Technique (Density Gradient Centrifugation Process and Leukapheresis)
6.2.4. By Source (Human and Animals)
6.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
6.2.6. By Company (2021)
6.3. Market Map
6.3.1. By Product
6.3.2. By Application
6.3.3. By Technique
6.3.4. By Source
6.3.5. By Region
7. NORTH AMERICA PERIPHERAL BLOOD MONONUCLEAR CELLS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Application
7.2.3. By Technique
7.2.4. By Source
7.2.5. By Country
7.3. North America: Country Analysis
7.3.1. United States Peripheral Blood Mononuclear Cells Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.1.2.3. By Technique
7.3.1.2.4. By Source
7.3.2. Canada Peripheral Blood Mononuclear Cells Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.2.2.3. By Technique
7.3.2.2.4. By Source
7.3.3. Mexico Peripheral Blood Mononuclear Cells Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.3.2.3. By Technique
7.3.3.2.4. By Source
8. EUROPE PERIPHERAL BLOOD MONONUCLEAR CELLS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Application
8.2.3. By Technique
8.2.4. By Source
8.2.5. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Peripheral Blood Mononuclear Cells Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.1.2.3. By Technique
8.3.1.2.4. By Source
8.3.2. France Peripheral Blood Mononuclear Cells Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.2.2.3. By Technique
8.3.2.2.4. By Source
8.3.3. United Kingdom Peripheral Blood Mononuclear Cells Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.3.2.3. By Technique
8.3.3.2.4. By Source
8.3.4. Italy Peripheral Blood Mononuclear Cells Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.4.2.3. By Technique
8.3.4.2.4. By Source
8.3.5. Spain Peripheral Blood Mononuclear Cells Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
8.3.5.2.3. By Technique
8.3.5.2.4. By Source
9. ASIA-PACIFIC PERIPHERAL BLOOD MONONUCLEAR CELLS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Application
9.2.3. By Technique
9.2.4. By Source
9.2.5. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Peripheral Blood Mononuclear Cells Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.1.2.3. By Technique
9.3.1.2.4. By Source
9.3.2. Japan Peripheral Blood Mononuclear Cells Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.2.2.3. By Technique
9.3.2.2.4. By Source
9.3.3. India Peripheral Blood Mononuclear Cells Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
9.3.3.2.3. By Technique
9.3.3.2.4. By Source
9.3.4. South Korea Peripheral Blood Mononuclear Cells Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Product
9.3.4.2.2. By Application
9.3.4.2.3. By Technique
9.3.4.2.4. By Source
9.3.5. Australia Peripheral Blood Mononuclear Cells Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Product
9.3.5.2.2. By Application
9.3.5.2.3. By Technique
9.3.5.2.4. By Source
10. SOUTH AMERICA PERIPHERAL BLOOD MONONUCLEAR CELLS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Application
10.2.3. By Technique
10.2.4. By Source
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Peripheral Blood Mononuclear Cells Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.1.2.3. By Technique
10.3.1.2.4. By Source
10.3.2. Argentina Peripheral Blood Mononuclear Cells Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Application
10.3.2.2.3. By Technique
10.3.2.2.4. By Source
10.3.3. Colombia Peripheral Blood Mononuclear Cells Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Application
10.3.3.2.3. By Technique
10.3.3.2.4. By Source
11. MIDDLE EAST AND AFRICA PERIPHERAL BLOOD MONONUCLEAR CELLS MARKET OUTLOOK
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product
11.2.2. By Application
11.2.3. By Technique
11.2.4. By Source
11.2.5. By Country
11.3. MEA: Country Analysis
11.3.1. UAE Peripheral Blood Mononuclear Cells Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product
11.3.1.2.2. By Application
11.3.1.2.3. By Technique
11.3.1.2.4. By Source
11.3.2. Saudi Arabia Peripheral Blood Mononuclear Cells Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product
11.3.2.2.2. By Application
11.3.2.2.3. By Technique
11.3.2.2.4. By Source
11.3.3. South Africa Peripheral Blood Mononuclear Cells Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product
11.3.3.2.2. By Application
11.3.3.2.3. By Technique
11.3.3.2.4. By Source
12. MARKET DYNAMICS
12.1. Drivers
12.2. Challenges
13. MARKET TRENDS & DEVELOPMENTS
14. CLINICAL TRIAL ANALYSIS
14.1. Ongoing Clinical Trials
14.2. Completed Clinical Trials
14.3. Terminated Clinical Trials
14.4. Breakdown of Pipeline, By Development Phase
14.5. Breakdown of Pipeline, By Status
14.6. Breakdown of Pipeline, By Study Type
14.7. Breakdown of Pipeline, By Region
14.8. Clinical Trials Heat Map
15. COMPETITIVE LANDSCAPE
15.1. Competitive Outlook
15.2. Company Profiles
15.2.1. Charles River Laboratories International, Inc.
15.2.2. Lonza Group AG
15.2.3. Corning Inc
15.2.4. Bio-Rad Laboratories Inc
15.2.5. ABCAM
15.2.6. Biolegend Inc
15.2.7. ZEN-Bio Inc
15.2.8. DAPCEL, Inc.
15.2.9. Creative Bioarray
15.2.10. iXCells Biotechnologies USA, LLC
15.2.11. Miltenyi Biotec B.V. & CO. KG
15.2.12. STEMCELL Technologies Inc.
15.2.13. Precision Medicine Group, LLC.
15.2.14. StemExpress, LLC
15.2.15. RayBiotech Life, Inc.
15.2.16. REPROCELL Inc.
15.2.17. Cytologics LLC
15.2.18. BioIVT LLC
15.2.19. Biopredic International
15.2.20. Cell Applications, Inc.
16. STRATEGIC RECOMMENDATIONS
17. TECHSCI RESEARCH – AWARDS AND RECOGNITION
18. ABOUT US & DISCLAIMER
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. IMPACT OF COVID-19 ON GLOBAL PERIPHERAL BLOOD MONONUCLEAR CELLS MARKET
5. VOICE OF CUSTOMER
5.1. By Type of Product
5.2. By Type of Technique
5.3. Type of Application for Which PBMCs Are Used
5.4. Factors Driving Market Growth
6. GLOBAL PERIPHERAL BLOOD MONONUCLEAR CELLS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC and Peripheral Blood Mononuclear Cell Isolation & Viability Kits)
6.2.2. By Application (Immunology, Infectious Disease, Hematology and Others)
6.2.3. By Technique (Density Gradient Centrifugation Process and Leukapheresis)
6.2.4. By Source (Human and Animals)
6.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
6.2.6. By Company (2021)
6.3. Market Map
6.3.1. By Product
6.3.2. By Application
6.3.3. By Technique
6.3.4. By Source
6.3.5. By Region
7. NORTH AMERICA PERIPHERAL BLOOD MONONUCLEAR CELLS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Application
7.2.3. By Technique
7.2.4. By Source
7.2.5. By Country
7.3. North America: Country Analysis
7.3.1. United States Peripheral Blood Mononuclear Cells Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.1.2.3. By Technique
7.3.1.2.4. By Source
7.3.2. Canada Peripheral Blood Mononuclear Cells Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.2.2.3. By Technique
7.3.2.2.4. By Source
7.3.3. Mexico Peripheral Blood Mononuclear Cells Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.3.2.3. By Technique
7.3.3.2.4. By Source
8. EUROPE PERIPHERAL BLOOD MONONUCLEAR CELLS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Application
8.2.3. By Technique
8.2.4. By Source
8.2.5. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Peripheral Blood Mononuclear Cells Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.1.2.3. By Technique
8.3.1.2.4. By Source
8.3.2. France Peripheral Blood Mononuclear Cells Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.2.2.3. By Technique
8.3.2.2.4. By Source
8.3.3. United Kingdom Peripheral Blood Mononuclear Cells Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.3.2.3. By Technique
8.3.3.2.4. By Source
8.3.4. Italy Peripheral Blood Mononuclear Cells Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.4.2.3. By Technique
8.3.4.2.4. By Source
8.3.5. Spain Peripheral Blood Mononuclear Cells Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
8.3.5.2.3. By Technique
8.3.5.2.4. By Source
9. ASIA-PACIFIC PERIPHERAL BLOOD MONONUCLEAR CELLS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Application
9.2.3. By Technique
9.2.4. By Source
9.2.5. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Peripheral Blood Mononuclear Cells Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.1.2.3. By Technique
9.3.1.2.4. By Source
9.3.2. Japan Peripheral Blood Mononuclear Cells Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.2.2.3. By Technique
9.3.2.2.4. By Source
9.3.3. India Peripheral Blood Mononuclear Cells Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
9.3.3.2.3. By Technique
9.3.3.2.4. By Source
9.3.4. South Korea Peripheral Blood Mononuclear Cells Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Product
9.3.4.2.2. By Application
9.3.4.2.3. By Technique
9.3.4.2.4. By Source
9.3.5. Australia Peripheral Blood Mononuclear Cells Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Product
9.3.5.2.2. By Application
9.3.5.2.3. By Technique
9.3.5.2.4. By Source
10. SOUTH AMERICA PERIPHERAL BLOOD MONONUCLEAR CELLS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Application
10.2.3. By Technique
10.2.4. By Source
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Peripheral Blood Mononuclear Cells Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.1.2.3. By Technique
10.3.1.2.4. By Source
10.3.2. Argentina Peripheral Blood Mononuclear Cells Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Application
10.3.2.2.3. By Technique
10.3.2.2.4. By Source
10.3.3. Colombia Peripheral Blood Mononuclear Cells Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Application
10.3.3.2.3. By Technique
10.3.3.2.4. By Source
11. MIDDLE EAST AND AFRICA PERIPHERAL BLOOD MONONUCLEAR CELLS MARKET OUTLOOK
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product
11.2.2. By Application
11.2.3. By Technique
11.2.4. By Source
11.2.5. By Country
11.3. MEA: Country Analysis
11.3.1. UAE Peripheral Blood Mononuclear Cells Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product
11.3.1.2.2. By Application
11.3.1.2.3. By Technique
11.3.1.2.4. By Source
11.3.2. Saudi Arabia Peripheral Blood Mononuclear Cells Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product
11.3.2.2.2. By Application
11.3.2.2.3. By Technique
11.3.2.2.4. By Source
11.3.3. South Africa Peripheral Blood Mononuclear Cells Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product
11.3.3.2.2. By Application
11.3.3.2.3. By Technique
11.3.3.2.4. By Source
12. MARKET DYNAMICS
12.1. Drivers
12.2. Challenges
13. MARKET TRENDS & DEVELOPMENTS
14. CLINICAL TRIAL ANALYSIS
14.1. Ongoing Clinical Trials
14.2. Completed Clinical Trials
14.3. Terminated Clinical Trials
14.4. Breakdown of Pipeline, By Development Phase
14.5. Breakdown of Pipeline, By Status
14.6. Breakdown of Pipeline, By Study Type
14.7. Breakdown of Pipeline, By Region
14.8. Clinical Trials Heat Map
15. COMPETITIVE LANDSCAPE
15.1. Competitive Outlook
15.2. Company Profiles
15.2.1. Charles River Laboratories International, Inc.
15.2.2. Lonza Group AG
15.2.3. Corning Inc
15.2.4. Bio-Rad Laboratories Inc
15.2.5. ABCAM
15.2.6. Biolegend Inc
15.2.7. ZEN-Bio Inc
15.2.8. DAPCEL, Inc.
15.2.9. Creative Bioarray
15.2.10. iXCells Biotechnologies USA, LLC
15.2.11. Miltenyi Biotec B.V. & CO. KG
15.2.12. STEMCELL Technologies Inc.
15.2.13. Precision Medicine Group, LLC.
15.2.14. StemExpress, LLC
15.2.15. RayBiotech Life, Inc.
15.2.16. REPROCELL Inc.
15.2.17. Cytologics LLC
15.2.18. BioIVT LLC
15.2.19. Biopredic International
15.2.20. Cell Applications, Inc.
16. STRATEGIC RECOMMENDATIONS
17. TECHSCI RESEARCH – AWARDS AND RECOGNITION
18. ABOUT US & DISCLAIMER
LIST OF TABLES
Table 1: Global Cancer Statistics, 2020
Table 2: Total Number of New Cancer Cases and Deaths Reported Globally, By Type, 2020
Table 3: North America Cancer Statistics, 2020
Table 4: Total Number of New Cancer Cases and Deaths Reported in North America, By Type, 2020
Table 5: Europe Cancer Statistics, 2020
Table 6: Total Number of New Cancer Cases and Deaths Reported in Europe, By Type, 2020
Table 7: Asia Pacific Cancer Statistics, 2020
Table 8: Total Number of New Cancer Cases and Deaths Reported in Asia Pacific, By Type, 2020
Table 9: Middle East & Africa Cancer Statistics, 2020
Table 10: Total Number of New Cancer Cases and Deaths Reported in Middle East & Africa, By Type, 2020
Table 11: South America Cancer Statistics, 2020
Table 12: Total Number of New Cancer Cases and Deaths Reported in South America, By Type, 2020
Table 13: Pricing Analysis of PBMC Products
Table 14: Clinical Trial Analysis
Table 1: Global Cancer Statistics, 2020
Table 2: Total Number of New Cancer Cases and Deaths Reported Globally, By Type, 2020
Table 3: North America Cancer Statistics, 2020
Table 4: Total Number of New Cancer Cases and Deaths Reported in North America, By Type, 2020
Table 5: Europe Cancer Statistics, 2020
Table 6: Total Number of New Cancer Cases and Deaths Reported in Europe, By Type, 2020
Table 7: Asia Pacific Cancer Statistics, 2020
Table 8: Total Number of New Cancer Cases and Deaths Reported in Asia Pacific, By Type, 2020
Table 9: Middle East & Africa Cancer Statistics, 2020
Table 10: Total Number of New Cancer Cases and Deaths Reported in Middle East & Africa, By Type, 2020
Table 11: South America Cancer Statistics, 2020
Table 12: Total Number of New Cancer Cases and Deaths Reported in South America, By Type, 2020
Table 13: Pricing Analysis of PBMC Products
Table 14: Clinical Trial Analysis
LIST OF FIGURES
Figure 1: Global Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 2: Global Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 3: Global Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application Type, By Value, 2018-2028F
Figure 4: Global Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 5: Global Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 6: Global Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Region, By Value, 2018-2028F
Figure 7: Global Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Company, By Value, 2022
Figure 8: Global Peripheral Blood Mononuclear Cells Market (PBMCs) Map, By Product, Market Size (USD Billion) & Growth Rate (%), 2022
Figure 9: Global Peripheral Blood Mononuclear Cells Market (PBMCs) Map, By Application, Market Size (USD Billion) & Growth Rate (%), 2022
Figure 10: Global Peripheral Blood Mononuclear Cells Market (PBMCs) Map, By Technique, Market Size (USD Billion) & Growth Rate (%), 2022
Figure 11: Global Peripheral Blood Mononuclear Cells Market (PBMCs) Map, By Source, By Type, Market Size (USD Billion) & Growth Rate (%), 2022
Figure 12: Global Peripheral Blood Mononuclear Cells Market (PBMCs) Map, By Region, Market Size (USD Billion) & Growth Rate (%), 2022
Figure 13: North America Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 14: North America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 15: North America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 16: North America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 17: North America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 18: North America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Country, By Value, 2018-2028F
Figure 19: United States Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 20: United States Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 21: United States Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 22: United States Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 23: United States Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 24: Canada Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 25: Canada Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 26: Canada Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 27: Canada Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 28: Canada Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 29: Mexico Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 30: Mexico Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 31: Mexico Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 32: Mexico Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 33: Mexico Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 34: Europe Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 35: Europe Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 36: Europe Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 37: Europe Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 38: Europe Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 39: Europe Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Country, By Value, 2018-2028F
Figure 40: Germany Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 41: Germany Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 42: Germany Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 43: Germany Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 44: Germany Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 45: France Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 46: France Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 47: France Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 48: France Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 49: France Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 50: United Kingdom Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 51: United Kingdom Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 52: United Kingdom Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 53: United Kingdom Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 54: United Kingdom Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 55: Italy Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 56: Italy Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 57: Italy Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 58: Italy Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 59: Italy Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 60: Spain Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 61: Spain Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 62: Spain Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 63: Spain Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 64: Spain Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 65: Asia Pacific Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 66: Asia Pacific Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 67: Asia Pacific Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 68: Asia Pacific Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 69: Asia Pacific Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 70: Asia Pacific Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Country, By Value, 2018-2028F
Figure 71: China Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 72: China Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 73: China Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 74: China Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 75: China Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 76: Japan Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 77: Japan Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 78: Japan Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 79: Japan Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 80: Japan Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 81: India Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 82: India Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 83: India Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 84: India Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 85: India Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 86: South Korea Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 87: South Korea Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 88: South Korea Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 89: South Korea Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 90: South Korea Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 91: Australia Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 92: Australia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 93: Australia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 94: Australia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 95: Australia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 96: Singapore Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 97: Singapore Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 98: Singapore Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 99: Singapore Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 100: Singapore Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 101: Middle East & Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 102: Middle East & Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 103: Middle East & Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 104: Middle East & Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 105: Middle East & Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 106: Middle East & Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Country, By Value, 2018-2028F
Figure 107: UAE Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 108: UAE Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 109: UAE Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 110: UAE Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 111: UAE Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 112: Saudi Arabia Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 113: Saudi Arabia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 114: Saudi Arabia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 115: Saudi Arabia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 116: Saudi Arabia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 117: South Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 118: South Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 119: South Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 120: South Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 121: South Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 122: South America Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 123: South America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 124: South America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 125: South America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 126: South America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 127: South America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Country, By Value, 2018-2028F
Figure 128: Brazil Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 129: Brazil Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 130: Brazil Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 131: Brazil Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 132: Brazil Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 133: Argentina Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 134: Argentina Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 135: Argentina Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 136: Argentina Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 137: Argentina Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 138: Colombia Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 139: Colombia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 140: Colombia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 141: Colombia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 142: Colombia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 143: Global Percentage of Cell and Gene Therapy Clinical Trials as of 2019, Divided by Clinical Trial Phase
Figure 144: Peripheral Blood Mononuclear Cells: Breakdown of Pipeline, By Development Phase, 1992-2023
Figure 145: Peripheral Blood Mononuclear Cells: Breakdown of Pipeline, By Status, 1992-2023
Figure 146: Peripheral Blood Mononuclear Cells: Breakdown of Pipeline, By Study Type, 1992-2023
Figure 147: Peripheral Blood Mononuclear Cells: Breakdown of Pipeline, By Region, 1992-2023
Figure 148: Peripheral Blood Mononuclear Cells: Breakdown of Pipeline, By Year, 2017-2023
Figure 149: Peripheral Blood Mononuclear Cells: Clinical Trials Heat Map
Figure 1: Global Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 2: Global Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 3: Global Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application Type, By Value, 2018-2028F
Figure 4: Global Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 5: Global Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 6: Global Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Region, By Value, 2018-2028F
Figure 7: Global Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Company, By Value, 2022
Figure 8: Global Peripheral Blood Mononuclear Cells Market (PBMCs) Map, By Product, Market Size (USD Billion) & Growth Rate (%), 2022
Figure 9: Global Peripheral Blood Mononuclear Cells Market (PBMCs) Map, By Application, Market Size (USD Billion) & Growth Rate (%), 2022
Figure 10: Global Peripheral Blood Mononuclear Cells Market (PBMCs) Map, By Technique, Market Size (USD Billion) & Growth Rate (%), 2022
Figure 11: Global Peripheral Blood Mononuclear Cells Market (PBMCs) Map, By Source, By Type, Market Size (USD Billion) & Growth Rate (%), 2022
Figure 12: Global Peripheral Blood Mononuclear Cells Market (PBMCs) Map, By Region, Market Size (USD Billion) & Growth Rate (%), 2022
Figure 13: North America Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 14: North America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 15: North America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 16: North America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 17: North America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 18: North America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Country, By Value, 2018-2028F
Figure 19: United States Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 20: United States Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 21: United States Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 22: United States Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 23: United States Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 24: Canada Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 25: Canada Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 26: Canada Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 27: Canada Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 28: Canada Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 29: Mexico Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 30: Mexico Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 31: Mexico Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 32: Mexico Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 33: Mexico Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 34: Europe Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 35: Europe Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 36: Europe Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 37: Europe Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 38: Europe Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 39: Europe Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Country, By Value, 2018-2028F
Figure 40: Germany Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 41: Germany Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 42: Germany Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 43: Germany Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 44: Germany Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 45: France Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 46: France Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 47: France Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 48: France Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 49: France Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 50: United Kingdom Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 51: United Kingdom Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 52: United Kingdom Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 53: United Kingdom Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 54: United Kingdom Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 55: Italy Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 56: Italy Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 57: Italy Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 58: Italy Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 59: Italy Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 60: Spain Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 61: Spain Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 62: Spain Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 63: Spain Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 64: Spain Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 65: Asia Pacific Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 66: Asia Pacific Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 67: Asia Pacific Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 68: Asia Pacific Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 69: Asia Pacific Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 70: Asia Pacific Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Country, By Value, 2018-2028F
Figure 71: China Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 72: China Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 73: China Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 74: China Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 75: China Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 76: Japan Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 77: Japan Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 78: Japan Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 79: Japan Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 80: Japan Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 81: India Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 82: India Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 83: India Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 84: India Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 85: India Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 86: South Korea Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 87: South Korea Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 88: South Korea Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 89: South Korea Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 90: South Korea Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 91: Australia Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 92: Australia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 93: Australia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 94: Australia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 95: Australia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 96: Singapore Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 97: Singapore Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 98: Singapore Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 99: Singapore Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 100: Singapore Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 101: Middle East & Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 102: Middle East & Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 103: Middle East & Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 104: Middle East & Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 105: Middle East & Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 106: Middle East & Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Country, By Value, 2018-2028F
Figure 107: UAE Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 108: UAE Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 109: UAE Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 110: UAE Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 111: UAE Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 112: Saudi Arabia Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 113: Saudi Arabia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 114: Saudi Arabia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 115: Saudi Arabia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 116: Saudi Arabia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 117: South Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 118: South Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 119: South Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 120: South Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 121: South Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 122: South America Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 123: South America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 124: South America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 125: South America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 126: South America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 127: South America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Country, By Value, 2018-2028F
Figure 128: Brazil Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 129: Brazil Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 130: Brazil Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 131: Brazil Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 132: Brazil Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 133: Argentina Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 134: Argentina Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 135: Argentina Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 136: Argentina Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 137: Argentina Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 138: Colombia Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F
Figure 139: Colombia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F
Figure 140: Colombia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F
Figure 141: Colombia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F
Figure 142: Colombia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F
Figure 143: Global Percentage of Cell and Gene Therapy Clinical Trials as of 2019, Divided by Clinical Trial Phase
Figure 144: Peripheral Blood Mononuclear Cells: Breakdown of Pipeline, By Development Phase, 1992-2023
Figure 145: Peripheral Blood Mononuclear Cells: Breakdown of Pipeline, By Status, 1992-2023
Figure 146: Peripheral Blood Mononuclear Cells: Breakdown of Pipeline, By Study Type, 1992-2023
Figure 147: Peripheral Blood Mononuclear Cells: Breakdown of Pipeline, By Region, 1992-2023
Figure 148: Peripheral Blood Mononuclear Cells: Breakdown of Pipeline, By Year, 2017-2023
Figure 149: Peripheral Blood Mononuclear Cells: Clinical Trials Heat Map
